Johnson & Johnson shares rose during trading session on Wednesday after the announcement of a deal between the pharmaceutical company and the US federal government. The company revealed an agreement to sell 100 million doses of its vaccine, which is still in the process of testing, for a billion dollars to the United States, as part of the latter’s efforts to control the “Corona” virus crisis. In terms of trading, Johnson & Johnson rose 0.8% to close the session Wednesday at 148.4 dollars, and recorded the highest price at 149.3 dollars, while the lowest price was at 147.8 dollars.